Skip to main content
Clinical Trials/NCT06444945
NCT06444945
Enrolling by Invitation
N/A

Effects of Mulligan Mobilization With Movement as Compared to Kaltenborn Joint Mobilization in the Management of Knee Osteoarthritis

Foundation University Islamabad1 site in 1 country40 target enrollmentJune 10, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Knee Osteoarthritis
Sponsor
Foundation University Islamabad
Enrollment
40
Locations
1
Primary Endpoint
knee pain
Status
Enrolling by Invitation
Last Updated
last year

Overview

Brief Summary

This study is a randomised controlled trial and the purpose of this study is to determine the Effects of Mulligan mobilization with movement as compared to Kaltenborn joint mobilization in the management of knee osteoarthritis." To determine the effects of Mulligan MWM as compared to Kaltenborn joint mobilization in terms of pain, function, range of motion and gait in persons with knee osteoarthritis.

Registry
clinicaltrials.gov
Start Date
June 10, 2024
End Date
December 30, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Individuals aged 40-70 years (Osama et al, 2022)
  • Having KOA history of no less than 3 months
  • Knee pain less than 8/10 on numeric pain rating scale (NPRS).
  • Radiological evidence of grade III or less on Kellgren classification
  • Patients referred from rehab department

Exclusion Criteria

  • Those with signs of serious pathology, such as malignancy, inflammatory disorder or infection.
  • History of trauma or fractures in lower extremity.
  • Signs of lumbar radiculopathy or myelopathy.
  • History of knee surgery or replacement.
  • Receiving intra-articular steroid therapy in the preceding two months.

Outcomes

Primary Outcomes

knee pain

Time Frame: 2 weeks

knee pain will be measured using visual analogue scale (VAS) from 0-100mm.A higher score on VAS indicated greater pain.

Isometeric Muscle Strength

Time Frame: 2 weeks

Isometeric Muscle Strength will be quantified using dynamometer. A higher score on dynamometer signifies greater muscle strength and good prognosis.

Knee range of motion

Time Frame: 2 weeks

knee range of motion will be measured using a goniometer. A higher ROM signifies positive outcome.

Gait velocity

Time Frame: 2 weeks

Gait analysis will be done to analyze gait velocity. A greater gait velocity signifies positive outcome and prognosis.

Functional disability

Time Frame: 2 weeks

knee functional disability will be assessed using Knee Osteoarthritis and Outcome Score(KOOS) with a score ranging from 0-100. A lower score on KOOS signifies greater functional disability

Stride length

Time Frame: 2 weeks

Gait analysis will be done to analyze stride length. A greater stride length signifies positive outcome and prognosis.

Functional Capacity

Time Frame: 2 weeks

5 repetition sit to stand test will be used to determine knee related functional capacity which will be quantified in terms of time. A smaller time will denote greater functional capacity.

Walking related performance fatigability

Time Frame: 2 weeks

walking related performance fatigability will be measured using 6 minute walk test. Greater fatigibility indicates poorer outcome.

Study Sites (1)

Loading locations...

Similar Trials